Oneness Biotech Co Ltd (4743) — Capital Reinvestment Ratio

Latest as of September 2025: 0.41x

Oneness Biotech Co Ltd (4743) has a Capital Reinvestment Ratio of 0.41x as of September 2025, meaning it reinvests 0% of its operating cash flow (NT$14.32 Million) in capital expenditures (NT$5.92 Million). See 4743 equity to assets ratio to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.41x
Capex / Operating Cash Flow

Operating Cash Flow

NT$14.32 Million
TWD

Capital Expenditures

NT$5.92 Million
TWD

Data as of

Sep 2025
Most recent filing

Oneness Biotech Co Ltd Capital Reinvestment Ratio (2010–2020)

This chart tracks Oneness Biotech Co Ltd's Capital Reinvestment Ratio across 3 annual periods. Check cash flow reinvestment rate of Oneness Biotech Co Ltd to assess the company's total reinvestment commitment from operating cash flow.

Annual Capital Reinvestment Ratio for Oneness Biotech Co Ltd (2010–2020)

Year-by-year Capital Reinvestment Ratio for Oneness Biotech Co Ltd from 2010 to 2020. For live market cap and broader valuation context, see 4743 market cap.

Year Reinvestment Ratio Operating CF (TWD) Capital Expenditures YoY Change
2020 0.97x NT$158.14 Million NT$153.27 Million ▲ +151.7%
2012 0.39x NT$24.15 Million NT$9.30 Million ▲ +286.2%
2010 0.10x NT$153.25 Million NT$15.28 Million
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow